LabCorp CEO and Chairman David King talks about his rise to the top of the life science giant’s executive suite, striving to keep his ego under control, challenges of the job, the unfinished business of the company, and the commitment to its hometown. Oh, there’s also the debate about how to pronounce the company’s name.
Read More
In January LabCorp was named to Fortune magazine’s list of the “World’s Most Admired Companies.” Last year it was named to Forbes’ ranking of the “World’s Most Innovative Companies.” The Burlington-based company continues to grow in size and reputation. And driving LabCorp ever higher is David King, its chair and CEO, who talks about the “tremendous run” of the life science giant under his direction.
Read MoreLabCorp, which began in a basement in 1969, “Is living proof of home grown innovation,” David King, CEO and chair of the Burlington-based company told the NC CEO Forum Healthcare Summit earlier this week. The healthcare challenges in the state and the nation are likely to require continuing innovation, he said.
Read MoreLabCorp’s David King, venture capitalist Eric Linsley, BlueBird Bio COO Susanna High and LaunchBio CEO Joan Siefert Rose headline the lineup for the first WRAL TechWire Live event of 2018: The State of Biotech.
Read More
Given a boost by the new tax law, LabCorp beats Wall Street expectations for earnings, barely missed on revenue while setting expectations for earnings as much as $11.70 a share for 2018.
Read More
